Target Details
| UniProt AC | Q07889 |
|---|---|
| Gene Symbol | SOS1 |
| Protein Name | Son of sevenless homolog 1 |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00617 (RasGEF) PF00618 (RasGEF_N) PF00621 (RhoGEF) PF22697 (SOS1_NGEF_PH) |
Summary
- Multi-target molecules 766
- Clinical molecules 0
- Avg pChEMBL 8.12
KEGG Pathways (48)
- Acute myeloid leukemia
- Alcoholism
- B cell receptor signaling pathway
- Breast cancer
- Chemical carcinogenesis - reactive oxygen species
- Chemical carcinogenesis - receptor activation
- Chemokine signaling pathway
- Choline metabolism in cancer
- Chronic myeloid leukemia
- Colorectal cancer
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- Endometrial cancer
- ErbB signaling pathway
- Estrogen signaling pathway
- Fc epsilon RI signaling pathway
- Focal adhesion
- FoxO signaling pathway
- Gap junction
- Gastric cancer
- Glioma
- GnRH signaling pathway
- Growth hormone synthesis, secretion and action
- Hepatitis B
- Hepatitis C
- Hepatocellular carcinoma
- Human cytomegalovirus infection
- Human papillomavirus infection
- Insulin signaling pathway
- JAK-STAT signaling pathway
- MAPK signaling pathway
- MicroRNAs in cancer
- Natural killer cell mediated cytotoxicity
- Neurotrophin signaling pathway
- Non-small cell lung cancer
- PI3K-Akt signaling pathway
- Pathways in cancer
- Phospholipase D signaling pathway
- Prolactin signaling pathway
- Prostate cancer
- Proteoglycans in cancer
- Ras signaling pathway
- Regulation of actin cytoskeleton
- Relaxin signaling pathway
- Renal cell carcinoma
- T cell receptor signaling pathway
- Thermogenesis
- mTOR signaling pathway
Associated Diseases (3)
Active Molecules (766)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
STJIVFPUHQRHHP
|
9.1 | IC50 | 2 | — | |
RKWFDZPCFOPRML
|
9.0 | Ki | 2 | — | |
AFONTOFZLGSFJN
|
9.0 | IC50 | 2 | — | |
ANVFXKQPUNYNFQ
|
9.0 | IC50 | 2 | — | |
AOESUWNZWIYSQD
|
9.0 | IC50 | 2 | — | |
AVGPSKODRMSSRN
|
9.0 | IC50 | 2 | — | |
AZOLRVUYHYDBNS
|
9.0 | IC50 | 2 | — | |
BIEZLUTYPITYLL
|
9.0 | IC50 | 2 | — | |
BWDTYABKUHJYLG
|
9.0 | IC50 | 2 | — | |
BWYYHSVVJLPKFM
|
9.0 | IC50 | 2 | — | |
CAXXCLWELRCUAN
|
9.0 | IC50 | 2 | — | |
CCZMGVUPQVLFQE
|
9.0 | IC50 | 2 | — | |
CVBPUZNQQAXBNY
|
9.0 | IC50 | 2 | — | |
DDTMLXBXDLXCQJ
|
9.0 | IC50 | 2 | — | |
DNZUCCATXSQTCH
|
9.0 | IC50 | 2 | — | |
DXKABQFHYZUCPP
|
9.0 | IC50 | 2 | — | |
DZNGROXZPYYFNU
|
9.0 | IC50 | 2 | — | |
FHTWBXIIMXEFEM
|
9.0 | IC50 | 2 | — | |
FTWZLBLTONBYHH
|
9.0 | IC50 | 2 | — | |
GBCFKGCLSSSUMK
|
9.0 | IC50 | 2 | — | |
GQDNXPLBFKYEIJ
|
9.0 | IC50 | 2 | — | |
HAFQELLNTQJCIE
|
9.0 | IC50 | 2 | — | |
HEYHLAZVGYNRDI
|
9.0 | IC50 | 2 | — | |
ITNHEBFBXNEVBO
|
9.0 | IC50 | 2 | — | |
JLEBPUHEDRECFJ
|
9.0 | IC50 | 2 | — | |
JQNDAWNKRWEULB
|
9.0 | IC50 | 2 | — | |
JTVQRVWBSVMAPX
|
9.0 | IC50 | 2 | — | |
JWOHHSAARCFGLI
|
9.0 | IC50 | 2 | — | |
JWVRZIMDGQYNFL
|
9.0 | IC50 | 2 | — | |
JZPZUNIKIOONNK
|
9.0 | IC50 | 2 | — | |
KAUXDCSRKMUMLL
|
9.0 | IC50 | 2 | — | |
KPUMNLZNWCMNEJ
|
9.0 | IC50 | 2 | — | |
KWKCHNKUWLFWCU
|
9.0 | IC50 | 2 | — | |
KYWMFGRLQZUNRD
|
9.0 | IC50 | 2 | — | |
LDWCNOPYUQHSLO
|
9.0 | IC50 | 2 | — | |
LGMZCQHPANSOFF
|
9.0 | IC50 | 2 | — | |
LKXANKOOOCTHBY
|
9.0 | IC50 | 2 | — | |
LPUKIUZDTNDJCL
|
9.0 | IC50 | 2 | — | |
LWDVYKMOIBCPGL
|
9.0 | IC50 | 2 | — | |
MBGCKRDRMZFXKR
|
9.0 | IC50 | 2 | — | |
MEJJPCUDRQOGRP
|
9.0 | IC50 | 2 | — | |
MUQBVSDFTRUPST
|
9.0 | IC50 | 2 | — | |
NFQPEFIESBAWSQ
|
9.0 | IC50 | 2 | — | |
NUFDCNVCOXIFGR
|
9.0 | IC50 | 2 | — | |
OHWWJWNBZRICPR
|
9.0 | IC50 | 2 | — | |
OKYYBZYDGOYHDN
|
9.0 | IC50 | 2 | — | |
ONKIFAGLVVECAM
|
9.0 | IC50 | 2 | — | |
PDZRQJFCXGRUFO
|
9.0 | IC50 | 2 | — | |
PDZRQJFCXGRUFO
|
9.0 | IC50 | 2 | — | |
PGYXLQHSQVAQAG
|
9.0 | IC50 | 2 | — |